コンテンツへスキップ
Merck

1.24069

SAFC

炭酸カルシウム

EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, E170, FCC

医薬品製造

別名:

Calcium carbonate

ログイン組織・契約価格を表示する


About This Item

化学式:
CaCO3
CAS番号:
分子量:
100.09
Beilstein:
8008338
MDL番号:
UNSPSCコード:
12352302
E番号:
E170
EC Index Number:
207-439-9

グレード

GMO free
Halal
Kosher
cGMP

品質水準

認証

BP
Ph. Eur.
USP

法規制遵守

FCC

製品種目

EMPROVE® ESSENTIAL

フォーム

powder

密度

2.93 g/mL at 25 °C (lit.)

アプリケーション

pharmaceutical
solid formulation

その他の活性

Aflatoxin

保管温度

2-30°C

SMILES記法

[Ca++].[O-]C([O-])=O

InChI

1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2

InChI Key

VTYYLEPIZMXCLO-UHFFFAOYSA-L

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

アプリケーション

Due to regulatory developments, there is an increasing interest in titanium dioxide-free solutions for the coloring of solid dosage forms. Parteck® TA - our titanium dioxide alternative - is a mineral and nature-identical pigment specifically developed for the use in tablet film coatings. It helps to achieve a level of covering and whiteness comparable to titanium dioxide film coatings without affecting your tablets’ performance. The enhanced opacity is ensured by its unique morphology and designed particle size distribution

特徴および利点

  • A mineral, nature-identical pigment
  • Excellent compatibility with HPMC and PVA film coatings (including our PARTECK® COAT excipient)
  • High process efficiency due to lower viscosity of spraying liquids
  • Enables an appealing and uniform tablet appearance
  • Enhanced opacity due to tailored particle size distribution and unique morphology

法的情報

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

保管分類コード

13 - Non Combustible Solids

WGK

nwg

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

資料

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

関連コンテンツ

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)